BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Imstem Biotechnology

Imstem Biotechnology logo

Founded
2012
Patents
2
Clinical Trials
1
Publications
5

Technologies

Stem Cells Startups

ImStem Biotechnology is a drug-research platform designed to focus on treatment of heart, vascular and blood system and autoimmune diseases.

Posts Mentioning This Company

Mesenchymal Stem Cells to Battle COVID-19

  
What is a Mesenchymal Stem Cell? What Can it Do? Mesenchymal stem cells (MSCs) are multipotent stem/progenitor cells that are present in different tissues, including the umbilical cord, bone marrow, and fat tissue. MSCs can self-renew by dividing and differentiate into cells of bone, cartilage, muscle and fat cells, and …
SHARE